UBS Initiates Coverage On Pactiv Evergreen with Buy Rating, Announces Price Target of $19
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Curt Woodworth has initiated coverage on Pactiv Evergreen (NASDAQ:PTVE) with a Buy rating and set a price target of $19.
January 16, 2024 | 4:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS has initiated coverage on Pactiv Evergreen with a Buy rating and a price target of $19.
The initiation of coverage by UBS with a Buy rating typically indicates a positive outlook on the stock by the analyst, which can lead to increased investor interest and potentially a rise in the stock price in the short term. The price target of $19 suggests a significant upside from the current trading price, assuming the stock is trading below this target.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100